ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO456

Association between Peer Mentoring and Quality of Life among Patients with CKD

Session Information

Category: Chronic Kidney Disease (Non-Dialysis)

  • 306 CKD: Cognitive Dysfunction, Depression, Quality of Life

Authors

  • Mahmood, Hafiz Zafar Ahmed, Penn State College of Medicine, Hershey, Pennsylvania, United States
  • Ammar, Awais, Penn State College of Medicine, Hershey, Pennsylvania, United States
  • Wasserman, Emily J, Penn State College of Medicine, Hershey, Pennsylvania, United States
  • Liaghat, Tara, Penn State College of Medicine, Hershey, Pennsylvania, United States
  • Farooq, Umar, Penn State College of Medicine, Hershey, Pennsylvania, United States
  • Ghahramani, Nasrollah, Penn State College of Medicine, Hershey, Pennsylvania, United States
Background

Health related quality of life (HRQOL) has been increasingly recognized as an important medical outcome in patients with chronic kidney disease (CKD). Peer mentoring (PM) has been proposed as an effective model for active patient engagement and subsequent improvement in HRQOL. This study evaluates the preliminary effects of face-to-face peer mentoring on HRQOL among patients with chronic kidney disease.

Methods

Sixty-one patients with CKD were assigned to trained peer mentors with whom they had weekly phone contact and at least monthly face-to-face contact for a six month period. All participants completed a baseline Short Form Kidney Disease Quality of Life (KDQOL) instrument, developed as a self-report, health-related QOL tool designed specifically for patients with CKD. Currently, 25 patients have also completed the 12-month assessment. The Wilcoxon Signed Rank Test was used to evaluate paired differences in patient outcome measures for patients receiving face-to-face mentorship between the baseline and 12-month assessments (Change = Difference of 12-month assessment minus baseline assessment). All reported p-values are two-sided with a significance level of 0.05.

Results

There was a significant difference in the ‘Symptoms/Problems’ subscale (p=0.003; Median Change =6.25, IQR = 20.83, N=25) and the ‘Effects of Kidney Disease’ subscale (p=0.01; Median Change=12.50, IQR=25.00, N=25) of the KDQOL between the baseline and 12-month assessments. No significant differences were noted in the Burden of Kidney Disease (p=0.73, N=25), Physical Component Summary (p=0.89, N=15) and Mental Component Summary (p=0.30, N=15).

Conclusion

Face-to-face peer mentoring is associated with improved symptoms and problems subscale, as well as the effects of kidney disease subscale of the KDQOL instrument.

Funding

  • Other NIH Support